FLAVOCURE Trademark

Trademark Overview

On Sunday, February 19, 2017, a trademark application was filed for FLAVOCURE with the United States Patent and Trademark Office. The USPTO has given the FLAVOCURE trademark a serial number of 87341588. The federal status of this trademark filing is REGISTERED as of Tuesday, May 21, 2019. This trademark is owned by FLAVOCURE BIOTECH LLC. The FLAVOCURE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceuticals for the treatment of age-related diseases and cancer
flavocure

General Information

Serial Number87341588
Word MarkFLAVOCURE
Filing DateSunday, February 19, 2017
Status700 - REGISTERED
Status DateTuesday, May 21, 2019
Registration Number5758152
Registration DateTuesday, May 21, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2017

Trademark Statements

Goods and ServicesResearch and development of pharmaceuticals for the treatment of age-related diseases and cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 27, 2017
Primary Code042
First Use Anywhere DateMonday, October 19, 2015
First Use In Commerce DateMonday, October 19, 2015

Trademark Owner History

Party NameFLAVOCURE BIOTECH, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBALTIMORE, MD 21202
Party NameFLAVOCURE BIOTECH LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBALTIMORE, MD 21202
Party NameFLAVOCURE BIOTECH LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBALTIMORE, MD 21202
Party NameFLAVOCURE BIOTECH LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBALTIMORE, MD 21202

Trademark Events

Event DateEvent Description
Wednesday, January 20, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 21, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, April 16, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, April 15, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 26, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 19, 2019USE AMENDMENT FILED
Tuesday, March 26, 2019EXTENSION 3 GRANTED
Friday, February 22, 2019EXTENSION 3 FILED
Tuesday, March 19, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 20, 2019NOTICE OF REVIVAL - E-MAILED
Tuesday, March 19, 2019EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, March 19, 2019PETITION TO REVIVE-GRANTED
Tuesday, March 19, 2019TEAS PETITION TO REVIVE RECEIVED
Tuesday, March 19, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, August 28, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 27, 2018EXTENSION 2 GRANTED
Monday, August 20, 2018EXTENSION 2 FILED
Monday, August 27, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 20, 2018TEAS EXTENSION RECEIVED
Wednesday, February 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 19, 2018EXTENSION 1 GRANTED
Monday, February 19, 2018EXTENSION 1 FILED
Monday, February 19, 2018TEAS EXTENSION RECEIVED
Tuesday, August 22, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 27, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 27, 2017PUBLISHED FOR OPPOSITION
Wednesday, June 7, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 15, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 15, 2017ASSIGNED TO EXAMINER
Monday, February 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, February 22, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

flavocure diseases cancer related treatment development pharmaceuticals research